| (a) | by deleting item (8) of paragraph 1; |
| (b) | by deleting item (20) of paragraph 1 and substituting the following item:| “(20) | 2‑(4‑Bromo‑2,5‑dimethoxyphenyl)ethanamine (also known as 4‑bromo‑2,5‑dimethoxyphenethylamine or 2C‑B) and its bromo and dimethoxy positional isomers in the phenyl ring”; |
|
|
| (c) | by deleting items (44) and (45) of paragraph 1 and substituting the following items:| “(44) | 2,5‑Dimethoxy‑4,α‑dimethylphenethylamine (also known as 2‑amino‑1‑(2,5‑dimethoxy‑4‑methyl)phenylpropane or DOM) | | (45) | 2,5‑Dimethoxy‑α‑methylphenethylamine (also known as 2,5‑Dimethoxyamphetamine) and its dimethoxy positional isomers in the phenyl ring”; |
|
|
| (d) | by deleting item (86) of paragraph 1 and substituting the following item:| “(86) | p‑Methoxy‑α‑methylphenethylamine (also known as 4‑methoxyamphetamine or para‑methoxyamphetamine) and its methoxy positional isomers in the phenyl ring”; |
|
|
| (e) | by inserting, immediately after item (7) of paragraph 7, the following item:| “(7A) | Butyryl fentanyl (also known as butyrfentanyl)”; |
|
|
| (f) | by deleting items (1) and (2) of paragraph 16 and substituting the following items:| “(1) | 1‑(1,3‑Benzodioxol‑5‑yl)‑2‑(benzylamino)propan‑1‑one (also known as 3,4‑Methylenedioxy‑N‑benzylcathinone or BMDP) | | (1A) | 1‑(1,3‑Benzodioxol‑5‑yl)‑2‑(dimethylamino)‑1-propanone (also known as bk‑MDDMA) | | (2) | 1‑(1,3‑Benzodioxol‑5‑yl)‑2‑(ethylamino)propan‑1‑one (also known as ethylone or 3,4‑Methylenedioxy‑N‑ethylcathinone or bk‑MDEA or MDEC)”; |
|
|
| (g) | by deleting item (8A) of paragraph 16 and substituting the following items:| “(8A) | 2‑(Benzylamino)‑1‑(4‑methylphenyl)propan‑1‑one (also known as Benzedrone) | | (8AA) | 1‑(4‑Bromophenyl)‑2‑(methylamino)propan‑1‑one (also known as 4‑Bromomethcathinone or Brephedrone or 4‑BMC)”; |
|
|
| (h) | by inserting, immediately after item (8B) of paragraph 16, the following item:| “(8C) | 2‑(Diethylamino)‑1‑phenyl‑1‑propanone (also known as amfepramone or diethylpropion or diethylcathinone)”; |
|
|
| (i) | by deleting item (10A) of paragraph 16 and substituting the following items:| “(10A) | 2‑(Ethylamino)‑1‑(4‑ethylphenyl)propan‑1‑one (also known as 4‑Ethylethcathinone) | | (10B) | 2‑(Ethylamino)‑1‑(4‑fluorophenyl)propan‑1‑one (also known as 4‑Fluoroethcathinone or 4‑FEC)”; |
|
|
| (j) | by inserting, immediately after item (17) of paragraph 16, the following item:| “(17A) | 2‑(Methylamino)‑1‑(4‑methylphenyl)butan‑1‑one (also known as 4‑Methylbuphedrone or 4‑Me‑MABP)”; |
|
|
| (k) | by deleting item (19) of paragraph 16 and substituting the following item:| “(19) | 2‑(Methylamino)‑1‑phenylpentan‑1‑one (also known as pentedrone or α‑Methylaminovalerophenone)”; |
|
|
| (l) | by inserting, immediately after item (22) of paragraph 16, the following item:| “(22A) | 1‑(4‑Methylphenyl)‑2‑(pyrrolidin‑1‑yl)hexan‑1‑one (also known as 4‑Methyl‑α‑pyrrolidinohexanophenone or MPHP)”; |
|
|
| (m) | by inserting, immediately after item (23) of paragraph 16, the following item:| “(23A) | 1‑(4‑Methylphenyl)‑2‑(pyrrolidin‑1‑yl)propan‑1‑one (also known as 4‑Methyl‑α‑pyrrolidinopropiophenone or 4‑MePPP)”; |
|
|
| (n) | by deleting item (2B) of paragraph 18 and substituting the following item:| “(2B) | N‑(1‑Amino‑3,3‑dimethyl‑1‑oxobutan‑2‑yl)‑1-(cyclohexylmethyl)‑1H‑indazole‑3‑carboxamide (also known as MAB‑CHMINACA or ADB‑CHMINACA)”; |
|
|
| (o) | by deleting items (2J) and (2K) of paragraph 18 and substituting the following items:| “(2J) | N‑(1‑Amino‑1‑oxo‑3‑phenylpropan‑2‑yl)‑1-(5‑fluoropentyl)‑1H‑indazole‑3‑carboxamide (also known as PX‑2 or 5‑Fluoro‑APP‑PINACA) and its fluoro positional isomers in the pentyl group | | (2K) | N‑(1‑Amino‑1‑oxo‑3‑phenylpropan‑2‑yl)‑1-(5‑fluoropentyl)‑1H‑indole‑3‑carboxamide (also known as PX‑1 or 5‑Fluoro-APP-PICA) and its fluoro positional isomers in the pentyl group”; |
|
|
| (p) | by inserting, immediately after item (10A) of paragraph 18, the following item:| “(10B) | 3,4‑Dichloro‑N‑[2‑(dimethylamino)cyclohexyl]‑N-methylbenzamide (also known as U‑47700) and its dichloro positional isomers in the phenyl ring and diamino positional isomers in the cyclohexyl ring”; |
|
|
| (q) | by inserting, immediately after item (20) of paragraph 18, the following item:| “(20A) | 5‑Fluoropent‑1‑yl‑N‑naphthalen‑1‑yl‑1H‑indole‑3-carboxamide (also known as CBM‑2201, 5‑Fluoro‑NNEI, 5F‑NNEI or MN‑24F) and its fluoro positional isomers in the pentyl group”; |
|
|
| (r) | by deleting item (26) of paragraph 18 and substituting the following item:| “(26) | 9‑(Hydroxymethyl)‑6,6‑dimethyl‑3‑(2-methyloctan‑2‑yl)‑6a,7,10,10a‑tetrahydro‑6H‑benzo[c]chromen‑1‑ol (for example HU‑210, HU‑211)”; |
|
|
| (s) | by deleting item (28C) of paragraph 18 and substituting the following items:| “(28C) | Methyl 2‑[1‑(cyclohexylmethyl)‑1H‑indole-3‑carboxamido]‑3,3‑dimethylbutanoate (also known as Methyl N‑{[1‑(cyclohexylmethyl)‑1H‑indol‑3‑yl]carbonyl}‑3‑methyl‑L‑valinate or MDMB‑CHMICA) | | (28D) | Methyl 2‑[1‑(5‑fluoropentyl)‑1H‑indazole-3‑carboxamido]‑3‑methylbutanoate (also known as 5‑Fluoro‑AMB) and its fluoro positional isomers in the pentyl group”; and |
|
|
| (t) | by deleting item (36) of paragraph 18 and substituting the following items:| “(36) | Naphthalen‑1‑yl 5‑fluoropent‑1‑yl‑1H‑indole-3‑carboxylate (also known as NM‑2201 or CBL‑2201) and its fluoro positional isomers in the pentyl group | | (36A) | Naphthalen‑1‑yl(4‑pentyloxynaphthalen‑1‑yl)methanone (also known as CB‑13) | | (36B) | Naphthalen‑1‑yl[1‑(pent‑1‑yl)‑1H‑indazol-3‑yl]methanone (also known as THJ‑018)”. |
|
|
